Italian lawmakers have demanded formal approval for a controversial stem-cell therapy, but allowed some patients to continue treatment under stricter rules.
The Scientist
Most Recent
A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.
Clinical researchers need programming support to streamline their work, minimize error in the data, and find new trends that can point to better treatments.
NIH Director Francis Collins and colleagues announce plans to create a health-care research network to connect patients, doctors, and clinical researchers.
A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.
Advances in genomics and cancer biology will alter the design of human cancer studies.
Contributors
| April 1, 2013
Meet some of the people featured in the April 2013 issue of The Scientist.
A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.
The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.
Tailoring ethical oversight to participant-led research
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
